Whitehawk Therapeutics Inc
WHWKHealthcare|Biotechnology|US
$3.13
+0.11 (+3.64%)
Tangible Book / Share
$2.21
Cash / Share
$2.29
Ownership Breakdown
41.5%
Float
57.0M
Shares Outstanding
23.7M
Float Shares
Major Holders (32)
Combined: 224.1%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Behzad Aghazadeh | Individual | 19.99% | 18,292,675 | May 14, 2026 | 13D/G |
| Avoro Capital Advisors LLC | IA, OO | 19.99% | 15,893,516 | May 14, 2026 | 13D/G |
| Cowen Aaron | HC, IN | 9.99% | 4,727,510 | Mar 11, 2025 | 13D/G |
| Suvretta Capital Management, LLC | IA, OO | 9.99% | 4,727,510 | Mar 11, 2025 | 13D/G |
| Fan Yu | Individual | 9.40% | 5,679,253 | Aug 14, 2026 | 13D/G |
| QVT Financial LP | Partnership | 9.37% | 2,313,702 | Feb 14, 2025 | 13D/G |
| OrbiMed Genesis GP LLC | Other | 8.90% | 4,166,000 | May 15, 2025 | 13D/G |
| OrbiMed Advisors LLC | Investment adviser | 8.90% | 4,166,000 | May 15, 2025 | 13D/G |
| Averill Master Fund, Ltd. | Corporation | 8.90% | 4,189,490 | Mar 11, 2025 | 13D/G |
| Ally Bridge Group Global Life Science Capital Partners V, L.P. | Partnership | 8.10% | 4,861,314 | Aug 14, 2026 | 13D/G |
| ABG Global Life Science Capital Partners V GP, L.P. | Partnership | 8.10% | 4,861,314 | Aug 14, 2026 | 13D/G |
| ABG Global Life Science Capital Partners V GP Limited | Corporation | 8.10% | 4,861,314 | Aug 14, 2026 | 13D/G |
| Abg-Siv, L.P. | Partnership | 8.10% | 4,861,314 | Aug 14, 2026 | 13D/G |
| ABG V-SIV Limited | Corporation | 8.10% | 4,861,314 | Aug 14, 2026 | 13D/G |
| Anupam Dalal | HC, IN | 7.80% | 1,921,297 | Jan 24, 2025 | 13D/G |
| Acuta Capital Partners, LLC | IA, OO | 7.50% | 1,849,402 | Jan 24, 2025 | 13D/G |
| Acuta Capital Fund, LP | Partnership | 6.40% | 1,572,698 | Jan 24, 2025 | 13D/G |
| Coastlands Capital LP | IA, PN | 5.98% | 2,819,215 | Aug 25, 2025 | 13D/G |
| Matthew D. Perry | HC, IN | 5.98% | 2,819,215 | Aug 25, 2025 | 13D/G |
| Coastlands Capital LLC | HC, OO | 5.98% | 2,819,215 | Aug 25, 2025 | 13D/G |
| Coastlands Capital GP LLC | Other | 5.98% | 2,819,215 | Aug 25, 2025 | 13D/G |
| Coastlands Capital Partners LP | Partnership | 5.98% | 2,819,215 | Aug 25, 2025 | 13D/G |
| Leonard Braden Michael | Individual | 4.98% | 2,435,000 | Mar 5, 2025 | 13D/G |
| Neil Desai | Individual | 4.90% | 2,272,941 | Mar 6, 2025 | 13D/G |
| BML Investment Partners, L.P. | Partnership | 4.25% | 1,971,137 | Mar 5, 2025 | 13D/G |
| Avoro Ventures LLC | IA, OO | 4.10% | 2,288,950 | May 14, 2026 | 13D/G |
| ABG Management Ltd. | Corporation | 1.40% | 817,939 | Aug 14, 2026 | 13D/G |
| Ally Bridge Group (NY) LLC | Other | 1.40% | 817,939 | Aug 14, 2026 | 13D/G |
| Ally Bridge MedAlpha Master Fund L.P. | Partnership | 1.40% | 817,939 | Aug 14, 2026 | 13D/G |
| Oleg Nodelman | HC, IN | 1.40% | 345,253 | Feb 14, 2025 | 13D/G |
| EcoR1 Capital, LLC | IA, OO | 1.40% | 345,253 | Feb 14, 2025 | 13D/G |
| EcoR1 Capital Fund Qualified, L.P. | Partnership | 1.30% | 324,365 | Feb 14, 2025 | 13D/G |
Insider Trades (86)
Last 4 quarters: 15,960,277 acquired · 2,349,620 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Sep 15, 2026 | AWARD | 118,476 | $4.09 | $484.6K | Form 4 |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Sep 15, 2026 | AWARD | 118,476 | — | — | Form 4 |
| BALL BRYAN | See remarks | Sep 15, 2026 | AWARD | 91,633 | $4.09 | $374.8K | Form 4 |
| BALL BRYAN | See remarks | Sep 15, 2026 | AWARD | 91,633 | — | — | Form 4 |
| Dornan David | Chief Scientific Officer | Sep 15, 2026 | AWARD | 85,887 | $4.09 | $351.3K | Form 4 |
| Dornan David | Chief Scientific Officer | Sep 15, 2026 | AWARD | 85,887 | — | — | Form 4 |
| Lennon David James | director, officer: CHIEF EXECUTIVE OFFICER | Sep 15, 2026 | AWARD | 193,957 | $4.09 | $793.3K | Form 4 |
| Lennon David James | director, officer: CHIEF EXECUTIVE OFFICER | Sep 15, 2026 | AWARD | 193,957 | — | — | Form 4 |
| Dugan Margaret | Chief Medical Officer | Sep 15, 2026 | AWARD | 81,250 | $4.09 | $332.3K | Form 4 |
| Dugan Margaret | Chief Medical Officer | Sep 15, 2026 | AWARD | 81,250 | — | — | Form 4 |
| Lennon David James | director, officer: CHIEF EXECUTIVE OFFICER | Sep 15, 2026 | AWARD | 193,957 | $4.09 | $793.3K | Form 4 |
| Lennon David James | director, officer: CHIEF EXECUTIVE OFFICER | Sep 15, 2026 | AWARD | 193,957 | — | — | Form 4 |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Sep 15, 2026 | AWARD | 118,476 | $4.09 | $484.6K | Form 4 |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Sep 15, 2026 | AWARD | 118,476 | — | — | Form 4 |
| Dugan Margaret | Chief Medical Officer | Sep 15, 2026 | AWARD | 81,250 | $4.09 | $332.3K | Form 4 |
| Dugan Margaret | Chief Medical Officer | Sep 15, 2026 | AWARD | 81,250 | — | — | Form 4 |
| Dornan David | Chief Scientific Officer | Sep 15, 2026 | AWARD | 85,887 | $4.09 | $351.3K | Form 4 |
| Dornan David | Chief Scientific Officer | Sep 15, 2026 | AWARD | 85,887 | — | — | Form 4 |
| BALL BRYAN | See remarks | Sep 15, 2026 | AWARD | 91,633 | $4.09 | $374.8K | Form 4 |
| BALL BRYAN | See remarks | Sep 15, 2026 | AWARD | 91,633 | — | — | Form 4 |
| Iyengar Vijay K | director | Sep 9, 2026 | AWARD | 76,080 | $4.19 | $318.8K | Form 4 |
| Iyengar Vijay K | Sep 9, 2026 | OTHER | 0 | — | — | Form 4 | |
| Dalal Anupam | director | May 14, 2026 | AWARD | 1,275,510 | $3.92 | $5.0M | Form 4 |
| Dalal Anupam | director | Jun 12, 2026 | AWARD | 38,040 | $4.16 | $158.2K | Form 4 |
| Zhao Baiteng | director | Jun 12, 2026 | AWARD | 38,040 | $4.16 | $158.2K | Form 4 |
| Reeve Emma | director | Jun 12, 2026 | AWARD | 38,040 | $4.16 | $158.2K | Form 4 |
| Maroun Richard E | director | Jun 12, 2026 | AWARD | 38,040 | $4.16 | $158.2K | Form 4 |
| Hirmand Mohammad | director | Jun 12, 2026 | AWARD | 38,040 | $4.16 | $158.2K | Form 4 |
| Desai Neil | director | Jun 12, 2026 | AWARD | 38,040 | $4.16 | $158.2K | Form 4 |
| Castelein Caley | director | Jun 12, 2026 | AWARD | 38,040 | $4.16 | $158.2K | Form 4 |
| Aghazadeh Behzad | director, 10 percent owner, other: See remarks | Jun 12, 2026 | AWARD | 38,040 | $4.16 | $158.2K | Form 4 |
| Dugan Margaret | Chief Medical Officer | May 14, 2026 | AWARD | 19,132 | $3.92 | $75.0K | Form 4 |
| BALL BRYAN | See remarks | May 14, 2026 | AWARD | 51,020 | $3.92 | $200.0K | Form 4 |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | May 14, 2026 | AWARD | 38,265 | $3.92 | $150.0K | Form 4 |
| Lennon David James | director, officer: CHIEF EXECUTIVE OFFICER | May 14, 2026 | AWARD | 51,021 | $3.92 | $200.0K | Form 4 |
| Castelein Caley | director | May 14, 2026 | AWARD | 2,072,756 | $0.00 | $207.28 | Form 4 |
| Castelein Caley | director | May 14, 2026 | AWARD | 255,102 | $3.92 | $1000.0K | Form 4 |
| Avoro Capital Advisors LLC | director, 10 percent owner, other: See Remarks | May 12, 2026 | AWARD | 6,377,714 | $0.00 | $637.77 | Form 4 |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Apr 15, 2026 | SELL | 77,000 | $3.86 | $297.2K | Form 4 |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Apr 16, 2026 | SELL | 141,600 | $4.13 | $584.8K | Form 4 |
| BALL BRYAN | See remarks | Apr 13, 2026 | SELL | 26,389 | $3.46 | $91.3K | Form 4 |
| BALL BRYAN | See remarks | Apr 14, 2026 | SELL | 92,460 | $3.64 | $336.6K | Form 4 |
| BALL BRYAN | See remarks | Apr 9, 2026 | SELL | 50,000 | $3.57 | $178.5K | Form 4 |
| BALL BRYAN | See remarks | Apr 10, 2026 | SELL | 6,596 | $3.43 | $22.6K | Form 4 |
| Lennon David James | director, officer: CHIEF EXECUTIVE OFFICER | Apr 9, 2026 | SELL | 14,500 | $3.38 | $49.0K | Form 4 |
| Lennon David James | director, officer: CHIEF EXECUTIVE OFFICER | Apr 6, 2026 | SELL | 102,395 | $3.51 | $359.4K | Form 4 |
| Lennon David James | director, officer: CHIEF EXECUTIVE OFFICER | Apr 7, 2026 | SELL | 94,087 | $3.43 | $322.7K | Form 4 |
| Lennon David James | director, officer: CHIEF EXECUTIVE OFFICER | Apr 8, 2026 | SELL | 63,945 | $3.40 | $217.4K | Form 4 |
| Dornan David | Chief Scientific Officer | Apr 1, 2026 | AWARD | 282,340 | $3.54 | $999.5K | Form 4 |
| Dugan Margaret | Chief Medical Officer | Apr 1, 2026 | AWARD | 283,157 | $3.54 | $1.0M | Form 4 |
| BALL BRYAN | See remarks | Apr 1, 2026 | OPTION EX. | 366,532 | — | — | Form 4 |
| BALL BRYAN | See remarks | Apr 1, 2026 | AWARD | 250,058 | $3.54 | $885.2K | Form 4 |
| BALL BRYAN | See remarks | Apr 1, 2026 | OPTION EX. | 366,532 | — | — | Form 4 |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Apr 1, 2026 | OPTION EX. | 473,902 | — | — | Form 4 |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Apr 1, 2026 | AWARD | 300,677 | $3.54 | $1.1M | Form 4 |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Apr 1, 2026 | OPTION EX. | 473,902 | — | — | Form 4 |
| Lennon David James | director, officer: CHIEF EXECUTIVE OFFICER | Apr 1, 2026 | AWARD | 831,148 | $3.54 | $2.9M | Form 4 |
| Lennon David James | director, officer: CHIEF EXECUTIVE OFFICER | Apr 1, 2026 | OPTION EX. | 775,828 | — | — | Form 4 |
| Lennon David James | director, officer: CHIEF EXECUTIVE OFFICER | Apr 2, 2026 | SELL | 26,858 | $3.48 | $93.5K | Form 4 |
| Lennon David James | director, officer: CHIEF EXECUTIVE OFFICER | Apr 1, 2026 | OPTION EX. | 775,828 | — | — | Form 4 |
| Lennon David James | director, officer: CHIEF EXECUTIVE OFFICER | Mar 1, 2026 | OPTION EX. | 16,250 | — | — | Form 4 |
| Lennon David James | director, officer: CHIEF EXECUTIVE OFFICER | Mar 2, 2026 | SELL | 5,100 | $3.31 | $16.9K | Form 4 |
| Lennon David James | director, officer: CHIEF EXECUTIVE OFFICER | Mar 1, 2026 | OPTION EX. | 16,250 | — | — | Form 4 |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Mar 1, 2026 | OPTION EX. | 6,750 | — | — | Form 4 |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Mar 2, 2026 | SELL | 2,594 | $3.31 | $8.6K | Form 4 |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Mar 1, 2026 | OPTION EX. | 6,750 | — | — | Form 4 |
| BALL BRYAN | See remarks | Mar 1, 2026 | OPTION EX. | 5,000 | — | — | Form 4 |
| BALL BRYAN | See remarks | Mar 2, 2026 | SELL | 1,834 | $3.31 | $6.1K | Form 4 |
| BALL BRYAN | See remarks | Mar 1, 2026 | OPTION EX. | 5,000 | — | — | Form 4 |
| Dugan Margaret | Chief Medical Officer | Dec 1, 2025 | AWARD | 650,000 | $2.26 | $1.5M | Form 4 |
| Dugan Margaret | Chief Medical Officer | Dec 1, 2025 | AWARD | 55,309 | — | — | Form 4 |
| Dugan Margaret | Dec 1, 2025 | OTHER | 0 | — | — | Form 4 | |
| Zhao Baiteng | director | Jun 17, 2025 | AWARD | 40,006 | $2.04 | $81.6K | Form 4 |
| Desai Neil | director | Jun 12, 2025 | AWARD | 40,006 | $2.04 | $81.6K | Form 4 |
| Hirmand Mohammad | director | Jun 12, 2025 | AWARD | 40,006 | $2.04 | $81.6K | Form 4 |
| Maroun Richard E | director | Jun 12, 2025 | AWARD | 40,006 | $2.04 | $81.6K | Form 4 |
| Reeve Emma | director | Jun 12, 2025 | AWARD | 40,006 | $2.04 | $81.6K | Form 4 |
| Castelein Caley | director | Jun 12, 2025 | AWARD | 40,006 | $2.04 | $81.6K | Form 4 |
| Dalal Anupam | director | Jun 12, 2025 | AWARD | 40,006 | $2.04 | $81.6K | Form 4 |
| Aghazadeh Behzad | director, 10 percent owner, other: See remarks | Jun 12, 2025 | AWARD | 40,006 | $2.04 | $81.6K | Form 4 |
| BALL BRYAN | See remarks | Apr 1, 2025 | AWARD | 366,532 | $1.70 | $623.1K | Form 4 |
| BALL BRYAN | See remarks | Apr 1, 2025 | AWARD | 366,532 | — | — | Form 4 |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Apr 1, 2025 | AWARD | 473,902 | — | — | Form 4 |
| Giacobello Scott M. | CHIEF FINANCIAL OFFICER | Apr 1, 2025 | AWARD | 473,902 | $1.70 | $805.6K | Form 4 |
| Lennon David James | director, officer: CHIEF EXECUTIVE OFFICER | Apr 1, 2025 | AWARD | 775,828 | — | — | Form 4 |
| Lennon David James | director, officer: CHIEF EXECUTIVE OFFICER | Apr 1, 2025 | AWARD | 775,828 | $1.70 | $1.3M | Form 4 |